Only presentation β2m levels and detection of neoplastic plasma cells at 3 months after transplantation are significant predictors of outcome in multivariate analysis
| Factor . | Univariate . | Multivariate . |
|---|---|---|
| Age at transplantation, older than 55 years | 0.426 | NT |
| Sex, male | 0.078 | NT |
| Presentation creatinine, greater than 130 μM | 0.267 | NT |
| Presentation hemoglobin, less than 12 g/dL | 0.021 | 0.442 |
| Presentation β2m, greater than 4.0 mg/L | 0.016 | 0.050 |
| Immunofixation-negative after transplantation | 0.002 | 0.786 |
| Neoplastic plasma cells at 3 months after transplantation | 0.003 | 0.014 |
| Factor . | Univariate . | Multivariate . |
|---|---|---|
| Age at transplantation, older than 55 years | 0.426 | NT |
| Sex, male | 0.078 | NT |
| Presentation creatinine, greater than 130 μM | 0.267 | NT |
| Presentation hemoglobin, less than 12 g/dL | 0.021 | 0.442 |
| Presentation β2m, greater than 4.0 mg/L | 0.016 | 0.050 |
| Immunofixation-negative after transplantation | 0.002 | 0.786 |
| Neoplastic plasma cells at 3 months after transplantation | 0.003 | 0.014 |
Univariate analysis (log-rank test) of factors that may affect progression-free survival, and multivariate Cox-regression analysis of factors significant in univariate analysis.
NT indicates not tested.